BEONE MEDICINES USA, INC. (FORMERLY BEIGENE USA, INC.)

Lobbying for BEONE MEDICINES USA, INC (FORMERLY BEIGENE USA, INC.)

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 21, 2025

Expenses

$220,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Massachusetts

Official filing document

Government bodies contacted 4

Executive Office of the President (EOP)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 1

Health Issues

Issues related to drug pricing; Issues related to the drug approval and review process; issues related to operations of the Department of Veterans Affairs including work with clinical trials and research studies; implementation of the Inflation Reduction Act; ORPHAN Cures Act and pharmacy benefit manager legislation; ORPHAN Cures Act language in H.R. 1, One Big Beautiful Bill Act

Foreign interests disclosed 1

Section 7 of the LD-2: foreign entities that own part of the client, paid toward this lobbying, or stand to benefit from it.

BEONE MEDICINES LTD. (FORMERLY BEIGENE, LTD.)

Switzerland · 4051 Basel · owns 100% of the client · contributed $0.00

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.